Evidence map›Paper›PMID 19191635›Full record

GuidelineClinical infectious diseases : an official publication of the Infectious Diseases Society of America2009

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Peter G Pappas, Carol A Kauffman, David Andes, Daniel K Benjamin, Thierry F Calandra, John E Edwards, Scott G Filler, John F Fisher, Bart-Jan Kullberg, Luis Ostrosky-Zeichner and 5 more

2 registry-linked trialsOpen access · bronzeAbstract readPractice Guideline
In one paragraph

Guideline in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 964 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
964citing papers in PubMed, 1 pooled it
159.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01053884 phase2terminatednot on this map

Anidulafungin in Patients With Hematologic Malignancies - An Open-label, Prospective Study to Evaluate the Safety Profile at Prophylactic and Therapeutic Dosages

TypeinterventionalSponsorElisabethinen HospitalRan2009 to 2011Enrolled10ConditionsHematologic MalignanciesArmsAnidulafungin
NCT03148769 completednot on this mapstarted 2016, after this paper: background citation

Spanish Cohort of Bacteriemias 2016: Epidemiology, Clinical Management and Prognostic Factors at Diagnosis.

TypeobservationalSponsorFundación Pública Andaluza para la gestión de la Investigación en SevillaRan2016 to 2019Enrolled5,320ConditionsBacteremia
3 · Its place in the literature

Who cites it

964 citing papers in PubMed, 1 synthesis or guideline pooled it, 3,201 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Laryngotracheobronchitis due toRespirology case reports · 2026
    Article
  8. Article
  9. Microorganisms · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Interactions betweenInfection and immunity · 2026
    Article
  17. Article
  18. The pathogenicity and future treatment strategies ofFrontiers in cellular and infection microbiology · 2026
    Review
  19. Article
  20. Fungal necrotizing otitis externa; challenges in diagnosis and therapy.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article

904 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 13 institutions in 4 countries.

Peter G PappasDepartment of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama 35294-0006, USA. pappas@uab.edu
Carol A Kauffman
David Andes
Daniel K Benjamin
Thierry F Calandra
John E Edwards
Scott G Filler
John F Fisher
Bart-Jan Kullberg
Luis Ostrosky-Zeichner
Annette C Reboli
John H Rex
Thomas J Walsh
Jack D Sobel
Infectious Diseases Society of America
UCLA Medical Center · USAstraZeneca (United Kingdom) · GBAugusta University · USCooper University Hospital · USDuke Medical Center · USNational Cancer Institute · USRadboud University Medical Center · NLThe University of Texas Health Science Center at Houston · USUniversity Hospital of Lausanne · CHUniversity of Alabama at Birmingham · USUniversity of Wisconsin–Madison · USVA Ann Arbor Healthcare System · USWayne State University · US

Funding

Treatment of Infections in Immunocompromised Children with Cancer, HematopoieticZ01SC006830 · SC · DIVISION OF CLINICAL SCIENCES - NCI · PI WALSH, THOMAS J. · 1996 to 2008
$5.8M
Treatment of Infections in Immunocompromised ChildrenZIASC006830 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI WALSH, THOMAS J. · 2009 to 2009
$2.4M
Intramural NIH HHS Z01 SC006830
6 · The paper itself

Abstract

Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by health care providers who care for patients who either have or are at risk of these infections. Since 2004, several new antifungal agents have become available, and several new studies have been published relating to the treatment of candidemia, other forms of invasive candidiasis, and mucosal disease, including oropharyngeal and esophageal candidiasis. There are also recent prospective data on the prevention of invasive candidiasis in high-risk neonates and adults and on the empiric treatment of suspected invasive candidiasis in adults. This new information is incorporated into this revised document.

Indexed as

Antifungal AgentsCandidiasisHumansAntifungal Agents

Identifiers

PMID19191635
PMCPMC7294538
OpenAlexW2150428940

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.